
Desomorphine is a powerful opioid best known in illicit form as “krokodil.” A desomorphine use disorder is a pattern of opioid use in which a person continues using desomorphine despite serious physical, psychological, social, or safety-related harm. The condition is especially dangerous because illicit desomorphine is often injected and may contain caustic contaminants from crude, nonmedical production.
Clinically, the problem is usually understood as an opioid use disorder involving desomorphine rather than as a separate diagnostic category. The key concerns are compulsive use, craving, withdrawal, overdose risk, severe tissue damage, infection, and the way opioid dependence can narrow a person’s choices even when the consequences are obvious and frightening.
Table of Contents
- What Desomorphine Use Disorder Means
- How Desomorphine Affects the Brain and Body
- Symptoms of Desomorphine Use Disorder
- Physical Signs and Medical Red Flags
- Causes and Risk Factors
- Diagnosis and Assessment Context
- Complications and Long-Term Effects
What Desomorphine Use Disorder Means
Desomorphine use disorder means opioid use has become hard to control and continues despite harm. The substance involved is desomorphine, but the clinical pattern falls under opioid use disorder because desomorphine acts on opioid receptors and can produce tolerance, withdrawal, craving, and overdose.
Desomorphine is a semi-synthetic opioid related to morphine. In illicit settings, it is often referred to as krokodil, a name associated with severe skin and soft-tissue injuries that can follow injection. The drug has drawn attention because reported injuries can be dramatic, but the disorder itself is not defined by appearance alone. A person can meet criteria for opioid use disorder because of behavior, loss of control, craving, withdrawal, and functional decline even before obvious tissue damage appears.
A careful description matters because stigmatizing language can hide the actual medical problem. Desomorphine use disorder is not simply “bad choices” or a lack of willpower. Opioids can strongly reinforce repeated use by producing euphoria, sedation, pain relief, or temporary emotional escape. Over time, the brain and body adapt. A person may use not only to feel intoxicated, but also to avoid withdrawal, reduce distress, or function enough to get through the day.
The term “use disorder” also helps separate several related but different ideas:
- Use means the person has taken the substance.
- Intoxication means the person is currently affected by the drug.
- Physical dependence means the body has adapted and withdrawal may occur when use stops.
- Use disorder means the pattern of use causes impairment or distress, such as unsafe use, failed attempts to cut down, craving, or continued use despite serious consequences.
This distinction matters because not every exposed person has the same pattern, severity, or risk profile. However, desomorphine use is medically high risk because illicit formulations are unpredictable and are commonly associated with injection-related injury.
Desomorphine use disorder also often overlaps with broader mental health and substance use concerns. A person may have anxiety, depression, trauma symptoms, psychosis-like symptoms during intoxication or withdrawal, unstable sleep, chronic pain, or use of other substances. A full mental health evaluation may be relevant when symptoms, behavior changes, or safety concerns are present, but the core issue remains the opioid use pattern and its consequences.
How Desomorphine Affects the Brain and Body
Desomorphine affects the brain and body primarily as a potent opioid. It can cause short-term euphoria and sedation, but it can also suppress breathing, impair judgment, create physical dependence, and contribute to severe injury when injected in contaminated or caustic form.
Like other opioids, desomorphine acts mainly through mu-opioid receptors. These receptors are involved in pain relief, reward, sedation, and breathing regulation. When an opioid strongly activates this system, the person may feel warmth, relief, detachment from distress, or a powerful sense of calm. Those effects can reinforce repeated use, especially when someone is dealing with pain, withdrawal, emotional distress, or limited access to safer care.
The same opioid effects can become dangerous quickly. Sedation can progress to stupor or loss of consciousness. Breathing can become slow, shallow, irregular, or stop altogether. Pupils may become very small. Reflexes and coordination may be impaired, increasing the risk of falls, burns, injuries, unsafe driving, or unsafe decisions.
Desomorphine is also described as having a relatively rapid onset and short duration compared with some other opioids. A short duration can intensify repeated use because withdrawal or craving may return quickly. The person may begin using more often, spending more time obtaining or recovering from the drug, and organizing daily life around avoiding withdrawal. That cycle is a major reason opioid use disorders can become so consuming.
Illicit krokodil adds another layer of harm. The severe injuries associated with krokodil are not thought to be caused by desomorphine alone. They may also reflect toxic byproducts, irritants, poor sterility, repeated injection, vascular injury, and contaminants left in crude drug mixtures. These can damage skin, veins, muscle, bone, and internal organs.
The body systems most often affected include:
- Brain and nervous system: sedation, impaired judgment, confusion, memory problems, slowed reaction time, and possible hallucinations.
- Breathing: slowed or stopped breathing during intoxication or overdose.
- Skin and soft tissue: ulcers, abscesses, cellulitis, necrosis, gangrene, and scarring.
- Blood vessels and heart: vein damage, thrombosis, endocarditis, and circulation problems.
- Mouth, jaw, and bone: dental disease, mucosal injury, osteomyelitis, and osteonecrosis, especially in reported krokodil-related jaw cases.
- Liver, kidneys, and immune system: organ strain, infection risk, and complications related to contaminated injection.
These effects do not appear in the same way for every person. The exact risks depend on dose, frequency, route of use, contaminants, other substances used at the same time, nutrition, immune status, wound exposure, and access to timely medical evaluation.
Symptoms of Desomorphine Use Disorder
The main symptoms are loss of control over use, craving, withdrawal, tolerance, unsafe use, and continued use despite harm. Physical injury may be obvious in some cases, but the disorder is defined by the pattern of opioid use and its impact on daily life.
A person with desomorphine use disorder may take more than intended, use more often than planned, or feel unable to stop even after frightening consequences. Attempts to cut down may repeatedly fail. Much of the day may become organized around finding the drug, using it, hiding use, recovering from intoxication, or avoiding withdrawal.
Craving can be intense and intrusive. It may feel like a physical pull, a mental preoccupation, or a sudden urgency triggered by stress, pain, conflict, places, people, or withdrawal symptoms. Craving is not simply “wanting” the drug. In opioid use disorder, it can override long-term goals and immediate safety concerns.
Tolerance is another common feature. The person may need more of the drug to get the same effect, or the same amount may feel weaker over time. Tolerance can increase overdose risk because the person may use larger or more frequent amounts, especially when the strength or composition of the drug supply is unknown.
Withdrawal symptoms can occur when use stops or drops. Opioid withdrawal is often extremely uncomfortable and may include muscle aches, sweating, chills, nausea, vomiting, diarrhea, abdominal cramps, anxiety, insomnia, runny nose, watery eyes, yawning, gooseflesh, restlessness, and dilated pupils. Fear of withdrawal can become a major driver of continued use.
| Area affected | Possible symptoms or signs | Why it matters |
|---|---|---|
| Control over use | Using more than intended, failed attempts to cut down, repeated use despite harm | Suggests the pattern has moved beyond occasional or voluntary use |
| Craving and preoccupation | Strong urges, planning the day around use, distress when the drug is unavailable | Shows how opioid reinforcement can dominate attention and behavior |
| Physical dependence | Withdrawal symptoms when use stops or decreases | Can keep the cycle going even when the person wants to stop |
| Functioning | Missed responsibilities, conflict, isolation, financial strain, legal problems | Reflects clinically significant impairment |
| Safety | Injecting despite wounds, using alone, mixing substances, using in hazardous situations | Raises risk of overdose, infection, injury, and death |
Emotional and cognitive symptoms can also be part of the picture. Some people become unusually withdrawn, irritable, anxious, depressed, suspicious, or emotionally flat. Others have periods of confusion, poor concentration, memory gaps, or disorganized behavior. These changes may reflect intoxication, withdrawal, sleep loss, infection, trauma, co-occurring mental health conditions, or the effects of other substances.
Because the drug supply may be unpredictable, symptoms can vary from one episode to another. A person may appear sedated after one use and agitated, panicked, or confused after another, especially if other substances are involved.
Physical Signs and Medical Red Flags
The most visible signs often involve injection injury, opioid intoxication, withdrawal, and infection. Some signs require urgent professional evaluation because desomorphine-related complications can progress quickly and may become life-threatening.
Opioid intoxication may cause drowsiness, slurred speech, poor coordination, slowed thinking, small pupils, nausea, vomiting, itching, and reduced awareness. In severe cases, the person may be difficult to wake, breathe slowly, have blue or gray lips or fingertips, make gurgling sounds, or become unconscious. These are emergency warning signs.
Injection-related signs may include puncture marks, bruising, swollen veins, redness, warmth, tenderness, drainage, foul odor, ulcers, black or gray tissue, or wounds that do not heal. Krokodil-related injuries are often described as severe because tissue damage can extend below the skin into muscle, blood vessels, and bone. A wound may look small at first but represent deeper infection or vascular injury.
Medical red flags include:
- slowed, irregular, or absent breathing
- inability to wake the person
- blue, gray, or very pale lips or skin
- severe confusion, delirium, or new hallucinations
- high fever, shaking chills, or extreme weakness
- rapidly spreading redness, swelling, or severe pain around a wound
- blackened, gray, numb, or foul-smelling tissue
- chest pain, fainting, severe shortness of breath, or a new heart murmur
- severe dehydration from vomiting or diarrhea
- suicidal thoughts, violent agitation, or inability to stay safe
These signs fit the broader category of urgent mental health or neurological symptoms when they involve severe confusion, loss of consciousness, breathing problems, or immediate safety concerns.
Withdrawal has a different pattern. The person may be restless, sweating, yawning, shivering, nauseated, tearful, anxious, unable to sleep, and physically uncomfortable. Although opioid withdrawal is often less directly fatal than alcohol or sedative withdrawal, it can still become medically serious through dehydration, electrolyte problems, pregnancy-related risk, co-occurring illness, or return to high-risk use after a period of reduced tolerance.
There are also less visible physical clues. Weight loss, poor nutrition, dental problems, frequent skin infections, repeated absences, unexplained fatigue, wearing clothing to hide wounds, or avoiding medical visits may all raise concern. None of these signs proves desomorphine use disorder by itself, but together they can point toward a serious substance-related condition.
Causes and Risk Factors
Desomorphine use disorder usually develops from a combination of opioid reinforcement, physical dependence, environmental exposure, psychological vulnerability, and high-risk drug supply conditions. No single cause explains every case.
The pharmacology of opioids is central. Desomorphine can produce rapid relief or euphoria, followed by craving and withdrawal as the effects fade. This pattern can create both positive reinforcement, where the person seeks the drug for its effects, and negative reinforcement, where the person uses to avoid withdrawal or emotional distress.
Prior opioid exposure is a major risk factor. Many reported krokodil users had histories of heroin or other opioid use and shifted to desomorphine because of cost, availability, supply disruption, or dependence. A person who is already opioid-dependent may be especially vulnerable to using a cheaper or more accessible opioid despite knowing it is dangerous.
Risk factors can include:
- previous heroin, fentanyl, prescription opioid, or polysubstance use
- history of opioid withdrawal or high tolerance
- untreated pain, trauma symptoms, depression, anxiety, or severe stress
- family or peer environments where opioid use is common
- unstable housing, poverty, incarceration history, or limited access to care
- injection drug use and shared or nonsterile equipment
- limited knowledge of drug contents or potency
- using opioids with alcohol, benzodiazepines, sedatives, or other depressants
- social isolation, stigma, and fear of seeking medical help
Mental health factors do not mean the person is “causing” the disorder. They can increase vulnerability by making the short-term effects of opioids feel more relieving or necessary. Trauma, grief, chronic stress, and untreated psychiatric symptoms can also make it harder to recognize danger early or seek evaluation before consequences worsen.
The drug supply itself is a risk factor. Illicit desomorphine may be made under nonsterile conditions and can contain variable amounts of active drug plus toxic contaminants. A person may not know the strength, purity, or full contents of what they are injecting. This unpredictability increases the chance of overdose, poisoning, infection, and tissue destruction.
Stigma adds another risk. People who fear judgment may hide wounds, avoid disclosing substance use, or delay evaluation until complications are advanced. This can be especially harmful with krokodil-associated injuries because necrosis, deep infection, and bone involvement may not remain localized.
Diagnosis and Assessment Context
Diagnosis is based on a clinical assessment of opioid use patterns, impairment, distress, physical signs, and safety risks. A toxicology result may help, but it does not replace a careful history and examination.
In current psychiatric diagnosis, desomorphine use disorder is generally considered under opioid use disorder. The DSM-5-TR framework looks for a problematic pattern of opioid use causing clinically significant impairment or distress, with at least two criteria within a 12-month period. These include taking more than intended, unsuccessful efforts to cut down, craving, excess time spent obtaining or recovering from opioids, failure to meet responsibilities, continued use despite problems, reduced activities, hazardous use, continued use despite physical or psychological harm, tolerance, and withdrawal.
Severity depends on how many criteria are present. Mild opioid use disorder involves fewer criteria; severe opioid use disorder involves many criteria and often includes marked loss of control, high tolerance, withdrawal, and major functional impairment. With desomorphine, even a short apparent history can be medically serious because injection-related harm may advance quickly.
Assessment often includes direct, nonjudgmental questions about what was used, how often, how it was taken, whether other substances were involved, and what happened after use. Clinicians may ask about overdose symptoms, withdrawal, wounds, fever, chest symptoms, mental status changes, sexual health risk, pregnancy, suicidal thoughts, and prior complications.
Substance-focused drug use screening can help identify patterns of risk, but it is only one part of the picture. A person may minimize use because of shame, fear, legal concerns, or confusion. Collateral information from family or emergency responders may sometimes clarify what happened, though privacy and consent matter.
Toxicology screening can support assessment when intoxication, overdose, confusion, or polysubstance use is suspected. However, routine urine opioid screens may not detect every synthetic or semi-synthetic opioid, and desomorphine-specific confirmation may require specialized testing. A negative routine screen does not always rule out clinically important opioid exposure.
Physical examination can be especially important. Skin, veins, mouth, jaw, heart, lungs, abdomen, mental status, hydration, and neurological signs may all provide clues. Imaging, blood tests, cultures, or other investigations may be considered when there are signs of infection, tissue necrosis, bone involvement, organ injury, or altered mental status. The exact assessment depends on the symptoms and setting.
Differential diagnosis may include heroin or fentanyl use disorder, other substance use disorders, sedative intoxication, stimulant intoxication, delirium, psychosis, severe infection, traumatic injury, self-injury, vascular disease, and other causes of skin ulcers or necrosis. This is why the diagnosis should not rest on appearance alone.
Complications and Long-Term Effects
The major complications involve overdose, deep infection, tissue necrosis, bone damage, bloodborne infections, organ injury, cognitive changes, and worsening psychiatric symptoms. Desomorphine use disorder can affect nearly every part of life because opioid dependence and medical injury often reinforce each other.
Overdose is one of the most immediate dangers. Opioids can suppress breathing to the point that the brain and body do not receive enough oxygen. The risk is higher when the drug’s potency is unknown, when tolerance has changed, or when opioids are combined with alcohol, benzodiazepines, sedatives, or other respiratory depressants.
Skin and soft-tissue complications are strongly associated with illicit krokodil injection. Repeated injection can damage veins and surrounding tissue. Contaminants can irritate or poison tissue. Bacteria can enter through nonsterile injection. The result may be abscesses, cellulitis, ulcers, thrombophlebitis, necrotizing infection, gangrene, and severe scarring. In some cases, tissue death can expose deeper structures or lead to amputation.
Bone and oral complications are also well described. Reported krokodil-related cases include osteonecrosis of the jaw and facial bones, osteomyelitis, dental decay, periodontal disease, mucosal injury, and facial deformity. These complications can affect speech, eating, appearance, pain, and infection risk.
Cardiovascular and infectious complications may include endocarditis, sepsis, blood clots, pneumonia, hepatitis B, hepatitis C, and HIV. These risks are linked not only to the opioid itself, but also to injection practices, shared equipment, contaminated mixtures, delayed medical evaluation, and poor wound healing.
Neurological and psychiatric complications can be complex. A person may experience confusion, memory problems, poor concentration, hallucinations, paranoia, mood instability, anxiety, depression, insomnia, or agitation. Some symptoms may be substance-induced, while others may reflect an underlying condition, infection, sleep deprivation, trauma, or polysubstance exposure. New hallucinations, delusions, or disorganized thinking may require a focused psychosis evaluation, especially when symptoms persist beyond intoxication or withdrawal.
Functional complications are often severe. Desomorphine use disorder can disrupt work, school, parenting, relationships, finances, housing, legal stability, and personal safety. Because visible wounds may carry stigma, people may become more isolated and less likely to seek evaluation. Isolation can then worsen risk by increasing the chance of using alone, delaying care, or losing contact with people who might notice medical deterioration.
The long-term outlook depends on many factors, including the severity of opioid use disorder, extent of tissue injury, presence of infections, other substances used, mental health conditions, and how early complications are recognized. The most important point for condition awareness is that desomorphine use disorder is both a psychiatric substance use disorder and a high-risk medical condition. Serious symptoms should not be dismissed as only behavioral, and physical wounds should not be separated from the opioid use pattern that may be driving continued harm.
References
- Necrotic Lesions Associated with Desomorphine (“Krokodil”) Drug Abuse: a Systematic Review 2025 (Systematic Review)
- Opioid Use Disorder: Diagnosis 2024 (Guideline)
- Opioid Use Disorder: Evaluation and Management 2024 (Review)
- Opioid Toxicity 2025 (Review)
- Opioid Withdrawal 2023 (Review)
- Krokodil 2023 (Poison Center Resource)
Disclaimer
This content is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Desomorphine exposure, opioid overdose symptoms, severe wounds, confusion, or self-harm risk should be evaluated by qualified professionals without delay.
Thank you for taking the time to read about this serious condition; sharing accurate information may help someone recognize risk earlier and seek appropriate professional evaluation.





